Novonesis Bets €600 Million on India With Advanced Enzyme Manufacturing Hub in Maharashtra
The expanded facility is expected to become fully operational in 2030. Once completed, it will manufacture enzymes used across a wide range of industries, including biofuels, household-care products and food and beverages. Novonesis says the investment will substantially increase its production capacity as global demand for biological solutions continues to grow.